Article Versions Notes

Tsai M-J, Hung J-Y, Lee M-H, Kuo C-Y, Tsai Y-C, Tsai Y-M, Liu T-C, Yang C-J, Huang M-S, Chong I-W. Better Progression-Free Survival in Elderly Patients with Stage IV Lung Adenocarcinoma Harboring Uncommon Epidermal Growth Factor Receptor Mutations Treated with the First-line Tyrosine Kinase Inhibitors. Cancers. 2018; 10(11):434. https://doi.org/10.3390/cancers10110434

Tsai, Ming-Ju, Jen-Yu Hung, Mei-Hsuan Lee, Chia-Yu Kuo, Yu-Chen Tsai, Ying-Ming Tsai, Ta-Chih Liu, Chih-Jen Yang, Ming-Shyan Huang, and Inn-Wen Chong. 2018. "Better Progression-Free Survival in Elderly Patients with Stage IV Lung Adenocarcinoma Harboring Uncommon Epidermal Growth Factor Receptor Mutations Treated with the First-line Tyrosine Kinase Inhibitors" Cancers 10, no. 11: 434. https://doi.org/10.3390/cancers10110434

Tsai, M.-J., Hung, J.-Y., Lee, M.-H., Kuo, C.-Y., Tsai, Y.-C., Tsai, Y.-M., Liu, T.-C., Yang, C.-J., Huang, M.-S., & Chong, I.-W. (2018). Better Progression-Free Survival in Elderly Patients with Stage IV Lung Adenocarcinoma Harboring Uncommon Epidermal Growth Factor Receptor Mutations Treated with the First-line Tyrosine Kinase Inhibitors. Cancers, 10(11), 434. https://doi.org/10.3390/cancers10110434